Quetiapine: Clinical Trials

73 trials of Quetiapine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed, 8 unknown, 5 terminated, 4 withdrawn. 73 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 473Completed 53, Unknown 8, Terminated 5, Withdrawn 4, Recruiting 2, Active not recruiting 1

Follow Quetiapine: new trials by email Literature Review of Quetiapine trials Research Report on Quetiapine

Trials (filtered) newest first · largest first

All 73 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone, Quetiapine, Placebo - Delirium, Morality
Phase 4WithdrawnUniversity of Southern California2028-03-012026-05-04
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Cariprazine, Aripiprazole/Escitalopram combination, Quetiapine - Bipolar I Disorder, Depression
Phase 4Active not recruitingMassachusetts General Hospital27262024-10-012025-12-16
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium
Phase 4WithdrawnUniversity of Miami2023-03-282023-03-31
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Pimavanserin, Quetiapine - Parkinson's Disease Psychosis
Phase 4RecruitingVA Office of Research and Development3582022-10-242026-08-19
Comparing Antipsychotic Medications in LBD Over Time
Pimavanserin, Quetiapine - Parkinson's Disease Psychosis, Dementia With Lewy Bodies
Phase 4RecruitingThe University of Texas Health Science Center at San Antonio942022-04-222025-09-09
Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression
Quetiapine, Amantadine, Pramipexole - Treatment Resistant Depression
Phase 4UnknownAll India Institute of Medical Sciences, Bhubaneswar1502021-08-072023-08-22
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
Risperidone, Aripiprazole, Ziprasidone - Schizophrenia
Phase 4UnknownShanghai Mental Health Center3502021-05-012020-08-26
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
Digital Medicine System, Aripiprazole, Olanzapine - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.442018-05-212020-07-16
Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.
Quetiapine - Healthy
Phase 4CompletedLaboratorio Elea Phoenix S.A.242017-03-132017-10-23
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
Quetiapine, Placebo - Substance Use Disorders, Bipolar Disorder
Phase 4CompletedBoston Medical Center242017-01-202022-05-11
Lithium Versus Quetiapine in Treatment Resistant Depression
Quetiapine, Lithium - Depressive Disorder, Treatment-Resistant
Phase 4UnknownKing's College London2762016-11-012021-03-05
Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
Clozapine, Risperidone, Olanzapine - Bipolar Disorder
Phase 4UnknownHospital de Clinicas de Porto Alegre542015-10-012018-10-02
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features
Phase 4CompletedTechnical University of Munich212015-02-012018-10-11
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Quetiapine - Psychomotor Agitation
Phase 4CompletedUniversity of Tennessee Graduate School of Medicine822013-11-012015-11-24
Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
Lithium, Valproate, Oxcarbazepine - Bipolar Disorder
Phase 4UnknownGuiyun Xu1202013-09-012015-03-17
NMDA Antagonists in Bipolar Depression
Standard of Care, Ketamine, D-cycloserine - Bipolar Disorder
Phase 4CompletedNew York State Psychiatric Institute82013-03-012016-06-01
Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans
Quetiapine, Trazodone - Insomnia, Mental Health Disorder
Phase 4TerminatedVA Connecticut Healthcare System12012-07-012018-10-16
Algorithm Guided Treatment Strategies for Bipolar Depression
Lithium, Quetiapine, Shuganjieyu capsule - Bipolar Disorder
Phase 4UnknownShanghai Mental Health Center3602012-06-012017-10-05
Gao Bipolar Spectrum Lithium/Quetiapine Study
Lithium, Quetiapine - Bipolar Disorder
Phase 4TerminatedUniversity Hospitals Cleveland Medical Center422012-01-012017-08-16
Sequential Multiple Assignment Treatment for Bipolar Disorder
Lithium, Divalproex, Lamotrigine - Bipolar I Disorder, Bipolar II Disorder
Phase 4CompletedThe University of Texas Health Science Center at San Antonio1122011-06-012020-08-19

Showing 20 of 73. Sign in to see all of them.

Conditions studied

Schizophrenia (23)  ·  Bipolar Disorder (17)  ·  Psychotic Disorders (15)  ·  Depression (5)  ·  Substance-Related Disorders (5)  ·  Alcoholism (4)  ·  Psychomotor Agitation (4)  ·  Cocaine-Related Disorders (3)  ·  Dementia (3)  ·  Depressive Disorder, Treatment-Resistant (3)  ·  Fibromyalgia (3)  ·  Generalized Anxiety Disorder (3)  ·  Alzheimer Disease (2)  ·  Anxiety Disorders (2)  ·  Depressive Disorder, Major (2)

Sponsors

Massachusetts General Hospital (6)  ·  University of Cincinnati (4)  ·  Fundación Marques de Valdecilla (3)  ·  Shanghai Mental Health Center (3)  ·  University of Texas Southwestern Medical Center (3)  ·  National Institute of Mental Health (NIMH) (2)  ·  Northwell Health (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  University of Southern California (2)  ·  VA Office of Research and Development (2)  ·  All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Anne Katrine Pagsberg (1)  ·  Beth Israel Medical Center (1)  ·  Boston Medical Center (1)  ·  Cambridge Health Alliance (1)

Countries

United States (41)  ·  Germany (5)  ·  China (4)  ·  Spain (4)  ·  Brazil (2)  ·  Canada (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  India (1)  ·  Norway (1)  ·  Puerto Rico (1)  ·  Taiwan (1)

Top investigators

Benedicto Crespo-Facorro, Professor (3)  ·  Melissa P DelBello, MD (2)  ·  Alan I Green, MD (1)  ·  Albert J Arias, MD, MS (1)  ·  Amy Yule, M.D. (1)  ·  Anders Fink-Jensen, MD, professor, DMSci. (1)  ·  Andre Tapp, M.D. (1)  ·  Andreas Heinz, MD PhD (1)  ·  Andrew A Nierenberg, MD (1)  ·  Anne Katrine Pagsberg, MD, Ph.D. (1)  ·  Anothony Cleare (1)  ·  Brian Daley (1)  ·  Catherine M Kuza, MD, FASA (1)  ·  Charles L. Bowden, M.D. (1)

Results publications

PMID 22035648, PMID 29856773, PMID 30097769, PMID 38958149, PMID 10082232, PMID 12075033, PMID 15082703, PMID 15817019, PMID 1593914, PMID 16172203, PMID 16585434, PMID 16585435, PMID 16831113, PMID 17151158, PMID 17151159, PMID 18058285, PMID 18312058, PMID 19157776, PMID 19347026, PMID 19640511, PMID 19687169, PMID 19752841, PMID 19865006, PMID 20334680, PMID 20724402, PMID 20816031, PMID 20868641, PMID 20879830, PMID 21536693, PMID 21884578, PMID 21926597, PMID 22000938, PMID 22290266, PMID 22301509, PMID 22316567, PMID 22480442, PMID 23182527, PMID 23235268, PMID 23506796, PMID 23727135, PMID 24028745, PMID 24030617, PMID 24079855, PMID 24183751, PMID 24400912, PMID 24490070, PMID 24524169, PMID 24569099, PMID 24581550, PMID 24630140

NIH funding

2005 (2), 2009 (2), K12DA000357 (1), N01MH090001 (1), N01MH90001 (1), P30MH086045 (1), R01DA022221 (1), R01MH057292 (1), R01MH059312 (1), R01MH060845 (1), R21AA016372 (1), U01MH070007 (1), U01MH070008 (1), U01MH070009 (1), U01MH070010 (1)